IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Hahn F, Wangen C, Häge S, Peter AS, Dobler G, Hurst B, Julander J, Fuchs J, Ruzsics Z, Überla K, Jäck HM, Ptak R, Muehler A, Gröppel M, Vitt D, Peelen E, Kohlhof H, Marschall M.
Hahn F, et al. Among authors: kohlhof h.
Viruses. 2020 Dec 5;12(12):1394. doi: 10.3390/v12121394.
Viruses. 2020.
PMID: 33291455
Free PMC article.